XRF Scientific Ltd

AU:XRF Australia Conglomerates
Market Cap
$154.50 Million
AU$249.52 Million AUD
Market Cap Rank
#17904 Global
#270 in Australia
Share Price
AU$1.75
Change (1 day)
-0.29%
52-Week Range
AU$1.49 - AU$2.35
All Time High
AU$2.35
Categories
Companies in Australia Conglomerates
About

XRF Scientific Limited manufactures and markets precious metal products, specialized chemicals, and instruments for the scientific, analytical, construction material, and mining industries in Australia, Canada, and Europe. It operates through Capital Equipment, Precious Metals, and Consumables segments. The Capital Equipment segment manufactures sample preparation products and analytical instrume… Read more

XRF Scientific Ltd (XRF) - Net Assets

Latest net assets as of December 2025: AU$61.36 Million AUD

Based on the latest financial reports, XRF Scientific Ltd (XRF) has net assets worth AU$61.36 Million AUD as of December 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (AU$70.03 Million) and total liabilities (AU$8.67 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets AU$61.36 Million
% of Total Assets 87.62%
Annual Growth Rate 14.29%
5-Year Change 53.87%
10-Year Change 97.88%
Growth Volatility 23.15

XRF Scientific Ltd - Net Assets Trend (2005–2025)

This chart illustrates how XRF Scientific Ltd's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for XRF Scientific Ltd (2005–2025)

The table below shows the annual net assets of XRF Scientific Ltd from 2005 to 2025.

Year Net Assets Change
2025-06-30 AU$60.17 Million +8.33%
2024-06-30 AU$55.54 Million +12.03%
2023-06-30 AU$49.58 Million +14.37%
2022-06-30 AU$43.35 Million +10.86%
2021-06-30 AU$39.10 Million +9.73%
2020-06-30 AU$35.64 Million +5.39%
2019-06-30 AU$33.81 Million +6.58%
2018-06-30 AU$31.72 Million +3.13%
2017-06-30 AU$30.76 Million +1.17%
2016-06-30 AU$30.41 Million +2.16%
2015-06-30 AU$29.77 Million +2.22%
2014-06-30 AU$29.12 Million +0.20%
2013-06-30 AU$29.06 Million +9.59%
2012-06-30 AU$26.52 Million +36.65%
2011-06-30 AU$19.41 Million +31.63%
2010-06-30 AU$14.74 Million -2.54%
2009-06-30 AU$15.13 Million +11.19%
2008-06-30 AU$13.60 Million +11.55%
2007-06-30 AU$12.20 Million +44.98%
2006-06-30 AU$8.41 Million +102.16%
2005-06-30 AU$4.16 Million --

Equity Component Analysis

This analysis shows how different components contribute to XRF Scientific Ltd's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 5827.1% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (June 2025)

Component Amount Percentage
Retained Earnings AU$32.23 Million 53.56%
Common Stock AU$24.96 Million 41.49%
Other Comprehensive Income AU$2.98 Million 4.95%
Total Equity AU$60.17 Million 100.00%

XRF Scientific Ltd Competitors by Market Cap

The table below lists competitors of XRF Scientific Ltd ranked by their market capitalization.

Company Market Cap
Jiangsu Cowin Biotech Co. Ltd. A
SHG:688426
 		$108.49 Million
OBI Pharma
TWO:4174
 		$108.50 Million
Orion Office Reit Inc
NYSE:ONL
 		$108.50 Million
JEIO CO LTD (PROPOSED)
KQ:418550
 		$108.52 Million
Ca Toulouse 31 CCI
PA:CAT31
 		$108.47 Million
EVI INDS INC. DL-025
F:2YE
 		$108.40 Million
CARASENT ASA NK 1332
F:C34
 		$108.35 Million
Doubleview Gold Corp
OTCQB:DBLVF
 		$108.33 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in XRF Scientific Ltd's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2024 to 2025, total equity changed from 54,885,033 to 60,168,225, a change of 5,283,192 (9.6%).
  • Net income of 10,383,453 contributed positively to equity growth.
  • Dividend payments of 4,515,681 reduced retained earnings.
  • Other comprehensive income increased equity by 1,276,971.
  • Other factors decreased equity by 1,861,551.

Equity Change Factors (2024 to 2025)

Factor Impact Contribution
Net Income AU$10.38 Million +17.26%
Dividends Paid AU$4.52 Million -7.51%
Other Comprehensive Income AU$1.28 Million +2.12%
Other Changes AU$-1.86 Million -3.09%
Total Change AU$- 9.63%

Book Value vs Market Value Analysis

This analysis compares XRF Scientific Ltd's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 4.06x
  • The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
  • The price-to-book ratio has decreased from 32.46x to 4.06x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2005-06-30 AU$0.05 AU$1.75 x
2006-06-30 AU$0.11 AU$1.75 x
2007-06-30 AU$0.15 AU$1.75 x
2008-06-30 AU$0.14 AU$1.75 x
2009-06-30 AU$0.17 AU$1.75 x
2010-06-30 AU$0.16 AU$1.75 x
2011-06-30 AU$0.19 AU$1.75 x
2012-06-30 AU$0.21 AU$1.75 x
2013-06-30 AU$0.22 AU$1.75 x
2014-06-30 AU$0.22 AU$1.75 x
2015-06-30 AU$0.23 AU$1.75 x
2016-06-30 AU$0.23 AU$1.75 x
2017-06-30 AU$0.23 AU$1.75 x
2018-06-30 AU$0.24 AU$1.75 x
2019-06-30 AU$0.25 AU$1.75 x
2020-06-30 AU$0.27 AU$1.75 x
2021-06-30 AU$0.29 AU$1.75 x
2022-06-30 AU$0.32 AU$1.75 x
2023-06-30 AU$0.36 AU$1.75 x
2024-06-30 AU$0.40 AU$1.75 x
2025-06-30 AU$0.43 AU$1.75 x

Capital Efficiency Dashboard

This dashboard shows how efficiently XRF Scientific Ltd utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): 17.26%
  • The company demonstrates strong efficiency in generating profits from shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: 17.47%
  • • Asset Turnover: 0.82x
  • • Equity Multiplier: 1.21x
  • Recent ROE (17.26%) is above the historical average (9.66%), indicating improving capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2005 13.15% 9.25% 0.85x 1.67x AU$132.57K
2006 7.50% 10.48% 0.54x 1.32x AU$-210.25K
2007 0.89% 0.86% 0.84x 1.23x AU$-1.11 Million
2008 6.77% 6.26% 0.94x 1.15x AU$-439.80K
2009 12.90% 11.54% 1.00x 1.12x AU$437.96K
2010 2.05% 2.39% 0.75x 1.14x AU$-1.17 Million
2011 13.58% 12.86% 0.85x 1.25x AU$694.47K
2012 13.50% 13.83% 0.85x 1.15x AU$927.71K
2013 13.12% 16.43% 0.74x 1.08x AU$906.73K
2014 8.38% 11.17% 0.69x 1.08x AU$-470.58K
2015 8.87% 12.77% 0.65x 1.07x AU$-337.07K
2016 5.06% 7.27% 0.63x 1.11x AU$-1.50 Million
2017 2.58% 3.69% 0.62x 1.13x AU$-2.28 Million
2018 3.23% 4.22% 0.64x 1.20x AU$-2.15 Million
2019 6.32% 7.36% 0.70x 1.23x AU$-1.24 Million
2020 8.76% 10.73% 0.64x 1.27x AU$-442.17K
2021 13.12% 16.40% 0.65x 1.24x AU$1.22 Million
2022 13.99% 15.21% 0.72x 1.28x AU$1.74 Million
2023 15.60% 13.93% 0.84x 1.33x AU$2.76 Million
2024 16.19% 14.85% 0.88x 1.24x AU$3.40 Million
2025 17.26% 17.47% 0.82x 1.21x AU$4.37 Million

Industry Comparison

This section compares XRF Scientific Ltd's net assets metrics with peer companies in the Conglomerates industry.

Industry Context

  • Industry: Conglomerates
  • Average net assets among peers: $1,026,970,068
  • Average return on equity (ROE) among peers: -7.63%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
XRF Scientific Ltd (XRF) AU$61.36 Million 13.15% 0.14x $108.48 Million
Alfabs Australia Ltd (AAL) $20.68 Million 15.47% 2.20x $19.13 Million
GREEN360 Technologies Ltd (GT3) $12.03 Million -63.49% 0.59x $16.96 Million
Infratil Ltd (IFT) $3.34 Billion 7.22% 1.27x $5.19 Billion
SGH Ltd (SGH) $1.00 Billion -0.03% 1.06x $5.37 Billion
SEVEN GROUP HOLDINGS LTD (SVW) $759.49 Million 2.68% 1.86x $272.77K